Pfizer Consumer Healthcare's sales fall 9% in US

31 January 2018 - Deborah Wilkes


Worldwide sales at Pfizer's Consumer Healthcare business decreased by 2% on an operational basis in the fourth quarter of 2017, as sales in the US dropped by 9%.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: